PURPOSE: To validate flow assessment performed with three-dimensional (3D) three-directional velocity-encoded (VE) magnetic resonance (MR) imaging with retrospective valve tracking and to compare this modality with conventional two-dimensional (2D) one-directional VE MR imaging in healthy subjects and patients with regurgitation. MATERIALS AND METHODS: Patients and volunteers gave informed consent, and local medical ethics committee approval was obtained. Patient data were selected retrospectively and randomly from a database of MR studies obtained between July 2006 and July 2007. The 3D three-directional VE MR images were first validated in vitro and compared with 2D one-directional VE MR images. Mitral valve (MV) and tricuspid valve (TV) flow were assessed in 10 volunteers without valve insufficiency and 20 patients with valve insufficiency, with aortic systolic stroke volume (ASSV) as the reference standard. RESULTS: Phantom validation showed less than 5% error for both techniques. In volunteers, 3D three-directional VE MR images showed no bias for MV or TV flow when compared with ASSV, whereas 2D one-directional VE MR images showed significant bias for MV flow (15% overestimation, P < .01). TV flow showed 25% overestimation; however, this was insignificant because of the high standard deviation. Correlation with ASSV was strong for 3D three-directional VE MR imaging (r = 0.96, P < .01 for MV flow; r = 0.88, P < .01 for TV flow) and between MV and TV flow (r = 0.91, P < .01); however, correlation was weaker for 2D one-directional VE MR imaging (r = 0.80, P < .01 for MV flow; r = 0.22, P = .55 for TV flow) and between MV flow and TV flow (r = 0.34, P = .34). In patients (mean regurgitation fractions of 13% and 10% for MV flow and TV flow, respectively), correlation between MV flow and TV flow for 3D three-directional VE MR imaging was strong (r = 0.97, P < .01). CONCLUSION: Use of 3D three-directional VE MR imaging enables accurate MV and TV flow quantification, even in patients with valve regurgitation. RSNA, 2008
PURPOSE: To validate flow assessment performed with three-dimensional (3D) three-directional velocity-encoded (VE) magnetic resonance (MR) imaging with retrospective valve tracking and to compare this modality with conventional two-dimensional (2D) one-directional VE MR imaging in healthy subjects and patients with regurgitation. MATERIALS AND METHODS:Patients and volunteers gave informed consent, and local medical ethics committee approval was obtained. Patient data were selected retrospectively and randomly from a database of MR studies obtained between July 2006 and July 2007. The 3D three-directional VE MR images were first validated in vitro and compared with 2D one-directional VE MR images. Mitral valve (MV) and tricuspid valve (TV) flow were assessed in 10 volunteers without valve insufficiency and 20 patients with valve insufficiency, with aortic systolic stroke volume (ASSV) as the reference standard. RESULTS: Phantom validation showed less than 5% error for both techniques. In volunteers, 3D three-directional VE MR images showed no bias for MV or TV flow when compared with ASSV, whereas 2D one-directional VE MR images showed significant bias for MV flow (15% overestimation, P < .01). TV flow showed 25% overestimation; however, this was insignificant because of the high standard deviation. Correlation with ASSV was strong for 3D three-directional VE MR imaging (r = 0.96, P < .01 for MV flow; r = 0.88, P < .01 for TV flow) and between MV and TV flow (r = 0.91, P < .01); however, correlation was weaker for 2D one-directional VE MR imaging (r = 0.80, P < .01 for MV flow; r = 0.22, P = .55 for TV flow) and between MV flow and TV flow (r = 0.34, P = .34). In patients (mean regurgitation fractions of 13% and 10% for MV flow and TV flow, respectively), correlation between MV flow and TV flow for 3D three-directional VE MR imaging was strong (r = 0.97, P < .01). CONCLUSION: Use of 3D three-directional VE MR imaging enables accurate MV and TV flow quantification, even in patients with valve regurgitation. RSNA, 2008
Authors: Kai Muellerleile; Michael Groth; Dennis Saring; Daniel Steven; Arian Sultan; Imke Drewitz; Boris Hoffmann; Jakob Lueker; Gerhard Adam; Gunnar K Lund; Stephan Willems; Thomas Rostock Journal: Eur Radiol Date: 2012-04-27 Impact factor: 5.315
Authors: Vivian P Kamphuis; Jos J M Westenberg; Roel L F van der Palen; Pieter J van den Boogaard; Rob J van der Geest; Albert de Roos; Nico A Blom; Arno A W Roest; Mohammed S M Elbaz Journal: Int J Cardiovasc Imaging Date: 2018-01-05 Impact factor: 2.357
Authors: Mieke M P Driessen; Johannes M P J Breur; Ricardo P J Budde; Joep W M van Oorschot; Roland R J van Kimmenade; Gertjan Tj Sieswerda; Folkert J Meijboom; Tim Leiner Journal: Pediatr Radiol Date: 2015-01-01
Authors: Anne Brandts; Stijntje D Roes; Joost Doornbos; Robert G Weiss; Albert de Roos; Matthias Stuber; Jos J M Westenberg Journal: J Magn Reson Imaging Date: 2010-05 Impact factor: 4.813
Authors: Mohammed S M Elbaz; Emmeline E Calkoen; Jos J M Westenberg; Boudewijn P F Lelieveldt; Arno A W Roest; Rob J van der Geest Journal: J Cardiovasc Magn Reson Date: 2014-09-27 Impact factor: 5.364
Authors: Yoichi Iwamoto; Akio Inage; George Tomlinson; Kyong Jin Lee; Lars Grosse-Wortmann; Mike Seed; Andrea Wan; Shi-Joon Yoo Journal: Pediatr Radiol Date: 2014-06-18
Authors: Anil K Attili; Andreas Schuster; Eike Nagel; Johan H C Reiber; Rob J van der Geest Journal: Int J Cardiovasc Imaging Date: 2010-02 Impact factor: 2.357